Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,520,877
+$418,993 QoQ
Shares Held
1,268
+5.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.79%
of 13F equity value
Holder Rank
#2,751
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sunpointe, LLC holds $9,495,332 across 8 Drug Manufacturers - General names. LLY ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,952 | $4,051,329 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
1,268 | $1,520,877 | |
| 3 | ABBV |
AbbVie Inc.
|
4,063 | $1,022,413 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,636 | $981,226 | |
| 5 | PFE |
Pfizer Inc
|
38,069 | $916,701 | |
| 6 | AMGN |
Amgen Inc
|
1,045 | $378,415 | |
| 7 | SNY |
Sanofi
|
7,549 | $322,040 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,393 | $302,331 |
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,520,877 | 1,268 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $1,101,884 | 1,198 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,318,632 | 1,227 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $878,976 | 1,152 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $922,183 | 1,183 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $850,687 | 1,030 | Shares | Defined | 2025-05-07 | |
| 2024-12-31 | $872,360 | 1,130 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $889,483 | 1,004 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $674,508 | 745 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $515,787 | 663 | Shares | Defined | 2024-04-15 | |
| 2023-12-31 | $366,073 | 628 | Shares | Defined | 2024-02-20 | |
| No filing history on record for this holder in this stock. | ||||||